돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 374355생성일: 2026년 10월 24일

Fluoxetine → 3-(Dimethylamino)-1-phenylpropan-1-ol

https://huagongshe.com/ko/reaction/374355

반응식

참여 물질

역할이름HCID투입량
반응물FluoxetineHCID 3386—
반응물1-Propanone, 3-(dimethylamino)-1-phenyl-, hydrochloride (1:1)HCID 92844—
반응물DiboronHCID 6328200—
생성물3-(Dimethylamino)-1-phenylpropan-1-olHCID 110665—

반응 단계

In the process for the preparation of fluoxetine, as in U.S. Pat. No. 4,314,081, β-dimethylaminopropiophenone hydrochloride is used as a starting material which, after the liberation of the base, is hydrogenated with diborane, B2H4. The N,N-dimethyl-3-hydroxy-3-phenylpropylamine produced in the reaction is allowed to react with thionyl chloride in chloroform containing hydrochloric acid yielding N,N-dimethyl-3-phenyl-3-chloropropylamine. This compound is allowed to react under alkaline conditions with p-trifluoro-methylphenol by heating the mixture under reflux for 5 days and nights, after which N,N-dimethyl-3-p-trifluoromethylphenoxy-3-phenylpropylamine is produced. This compound is N-demethylated with the aid of cyanogen bromide, yielding N-methyl-N-cyano-3-(p-trifuoromethylphenoxy)-phenylpropylamine. The N-cyano group is removed from this compound by heating for 20 hours at 130° C. under reflux in a mixture of potassium hydroxide and ethylene glycol. The reaction mixture is extracted with ether and the ether phase is evaporated to dryness. The residue could further be transformed in a known manner into a pharmaceutically acceptable salt of fluoxetine.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05166437
출처 데이터셋uspto-grants-1992_11
ORD IDord-6a6acbf10e9d48e18c50e2ffd34738cf
출처 메모uspto-grants-1992_11